UA27733C2 - Препарат людського фактора хі згортання крові та спосіб його одержання - Google Patents

Препарат людського фактора хі згортання крові та спосіб його одержання

Info

Publication number
UA27733C2
UA27733C2 UA93002714A UA93002714A UA27733C2 UA 27733 C2 UA27733 C2 UA 27733C2 UA 93002714 A UA93002714 A UA 93002714A UA 93002714 A UA93002714 A UA 93002714A UA 27733 C2 UA27733 C2 UA 27733C2
Authority
UA
Ukraine
Prior art keywords
concentrate
factor
blood coagulation
coagulation factor
preparing same
Prior art date
Application number
UA93002714A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Міріана Бюрнуф
Мириана Бюрнуф
Доменік Дерні
Доменик Дерни
Original Assignee
Ассосьасьон Пур Л`Ессор Де Ля Трансфюзьон Сангін Дан Ля Режьон Дю Нор
Ассосьасьон Пур Л’Ессор Де Ля Трансфюзьон Сангин Дан Ля Режьон Дю Нор
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ассосьасьон Пур Л`Ессор Де Ля Трансфюзьон Сангін Дан Ля Режьон Дю Нор, Ассосьасьон Пур Л’Ессор Де Ля Трансфюзьон Сангин Дан Ля Режьон Дю Нор filed Critical Ассосьасьон Пур Л`Ессор Де Ля Трансфюзьон Сангін Дан Ля Режьон Дю Нор
Publication of UA27733C2 publication Critical patent/UA27733C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21027—Coagulation factor XIa (3.4.21.27)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
UA93002714A 1991-05-07 1993-05-21 Препарат людського фактора хі згортання крові та спосіб його одержання UA27733C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105572A FR2676231A1 (fr) 1991-05-07 1991-05-07 Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.

Publications (1)

Publication Number Publication Date
UA27733C2 true UA27733C2 (uk) 2000-10-16

Family

ID=9412593

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93002714A UA27733C2 (uk) 1991-05-07 1993-05-21 Препарат людського фактора хі згортання крові та спосіб його одержання

Country Status (16)

Country Link
US (1) US5252217A (enExample)
EP (1) EP0512883B1 (enExample)
AT (1) ATE156360T1 (enExample)
AU (1) AU652043B2 (enExample)
BR (1) BR9201718A (enExample)
CA (1) CA2068069C (enExample)
DE (1) DE69221369T2 (enExample)
DK (1) DK0512883T3 (enExample)
EE (1) EE03017B1 (enExample)
ES (1) ES2107511T3 (enExample)
FR (1) FR2676231A1 (enExample)
GR (1) GR3025134T3 (enExample)
IL (1) IL99567A (enExample)
LT (1) LT3417B (enExample)
RU (1) RU2097047C1 (enExample)
UA (1) UA27733C2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2151604C1 (ru) * 1999-01-21 2000-06-27 Станкевич Виктор Евгеньевич Способ приготовления универсальной гемотрансфузионной среды
US20030040480A1 (en) * 2001-07-20 2003-02-27 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
JP2004534855A (ja) * 2001-07-20 2004-11-18 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドおよび第ｘｉ因子ポリペプチドを含んでなる医薬組成物
US20050181978A1 (en) * 2003-11-20 2005-08-18 Rasmus Rojkjaer Therapeutic use of factor XI
RU2006115783A (ru) * 2003-11-20 2007-12-27 Ново Нордиск Хелс Кеа Аг (Ch) Терапевтическое применение фактора xi
WO2006128497A1 (en) * 2005-06-01 2006-12-07 Novo Nordisk A/S Pharmaceutical formulation of factor xi
US8350013B2 (en) * 2006-09-08 2013-01-08 Wyeth Llc Arginine wash in protein purification using affinity chromatography
ATE546520T1 (de) * 2007-01-04 2012-03-15 Crucell Holland Bv Faktor-xi-reinigung
KR101979134B1 (ko) 2008-10-15 2019-05-15 아이오니스 파마수티컬즈, 인코포레이티드 인자 １１ 발현의 조정
FR2974366B1 (fr) 2011-04-20 2016-06-24 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur xi
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
IL212911A0 (en) 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
DE102012022233A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Verfahren zur Reinigung eines (Blut)plasmaproteins
DE102012022234A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Einstufiges Verfahren zur Reinigung von (Blut)Plasmaproteinen wie Albumin aus Gemischen
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법
MY204000A (en) 2018-05-09 2024-07-31 Ionis Pharmaceuticals Inc Compounds and methods for reducing fxi expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859340A (en) * 1976-03-15 1989-08-22 Cuno, Incorporated Filter sheet
US4783262A (en) * 1987-03-30 1988-11-08 Cuno Incorporated Separator for cell type filter element

Also Published As

Publication number Publication date
CA2068069A1 (en) 1992-11-08
EE03017B1 (et) 1997-08-15
BR9201718A (pt) 1992-12-29
FR2676231A1 (fr) 1992-11-13
AU1526392A (en) 1992-11-12
DE69221369D1 (de) 1997-09-11
DE69221369T2 (de) 1998-03-19
US5252217A (en) 1993-10-12
AU652043B2 (en) 1994-08-11
CA2068069C (en) 2005-03-15
DK0512883T3 (da) 1998-03-16
GR3025134T3 (en) 1998-02-27
EP0512883B1 (fr) 1997-08-06
LT3417B (en) 1995-09-25
IL99567A (en) 1996-01-19
ATE156360T1 (de) 1997-08-15
EP0512883A1 (fr) 1992-11-11
FR2676231B1 (enExample) 1995-04-21
LTIP265A (en) 1994-10-25
RU2097047C1 (ru) 1997-11-27
ES2107511T3 (es) 1997-12-01
IL99567A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
UA27733C2 (uk) Препарат людського фактора хі згортання крові та спосіб його одержання
DE69027311D1 (en) Neue chroman- und thiochromanderivate
DE3274951D1 (en) Composite semipermeable membrane, process for its production, and method of its use
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
PL285505A1 (en) Method of obtaining purifield albumin solutions
ATE88718T1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
ES2173927T3 (es) Procedimiento para la preparacion de un concentrado de inter-alfa-tripsina inhibidor de uso terapeutico, y concentrado obtenido.
EP0200169A3 (en) Pharmaceutical composition for cure and prevention of cardiovascular disease and method of preparing the same
FI903366A0 (fi) Foerfarande foer framstaellning av en mycket ren icke infektioes antihemofilifaktor genom kromatografi.
EP0232222A3 (en) Process for the preparation of brominated pyrrolo-û3,4-c¨-pyrroles
ES2111068T3 (es) Proteina anti-vih, tap 29, a partir de trichosanthes codificada adn y usos terapeuticos de la misma.
GR3020048T3 (en) Composition for stabilizing blood plasma during pasteurization
JPS6422395A (en) Two-bed type polisher device
DE3260564D1 (en) Process for the production of formaldehyde
IL71580A0 (en) Process for the purification of microbial protein isolates
UA8125A1 (uk) Спосіб підготовки води
EP0230956A3 (en) Method for the recovery and for the production of a pasteurized alpha-2-antiplasmin preparation
MX9703097A (es) Procedimiento para la produccion de formas inhibidas de factores de sangre activados.
JPS5765166A (en) Soy sauce with reduced salt and improved teste
JPS51143684A (en) Process for separating isopropylidenated nucleosides
CA1257205A (en) PLASMAPHERESIS BY RECIPROCAL PULSATILE FILTRATION